NCT03206853

Brief Summary

To evaluate the clinical benefits and risks of hybrid operating techniques in management of complex intracranial aneurysms, which could coexists with multiple risk factors.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
258

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 26, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 2, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

July 2, 2017

Status Verified

June 1, 2017

Enrollment Period

3.2 years

First QC Date

June 26, 2017

Last Update Submit

June 29, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • operation-related mortality rate

    the mortality rate related to the operation

    From the time of operation begin to 48 hours after operation

Secondary Outcomes (11)

  • Morbidity rate of peri-operative intracranial hemorrhage

    From date of admission to the 7 days after operation

  • Morbidity rate of peri-operative intracranial ischemic events

    From date of admission to 7 days after operation

  • Residual rate of aneurysms

    the date of first post-operative cerebrovascular angiography is conducted, up to 3 months after operation

  • Morbidity rate of neural functional deterioration in 48 hours after operation

    48 hours after operation, ±6 hours

  • Morbidity rate of neural functional deterioration in 7 days

    7 days after operation, ±2 days

  • +6 more secondary outcomes

Study Arms (2)

Hybrid operation group

EXPERIMENTAL

Intervene with hybrid operating techniques, eg. microsurgical clipping+endovascular coiling or with the assistant of balloon occlusion.

Procedure: Hybrid Operating Techniques

Traditional therapy group

OTHER

The aneurysms will be executed by traditional procedure, including microsurgical clipping, endovascular coiling or stenting, etc.

Procedure: Hybrid Operating Techniques

Interventions

It is a cooperation of existing endovascular interventional techniques and microsurgical techniques. Different from traditional management, hybrid operating techniques make it possible for 2 existing techniques conducting simultaneously in a hybrid operating theater. It optimizes the traditional microsurgical techniques for complex intracranial aneurysms and avoids the transportation of patients and the risks of intervals between stages in traditional ones. It includes balloon-assisted parental arterial occlusion, one-stage aneurysm clipping/wrapping/isolation and embolization/diverter implantation, etc.

Also known as: microsurgical clipping, microsurgical dissection, microsurgical wrapping, microsurgical isolation, endovascular coiling, balloon-assisted occlusion, flow diverter
Hybrid operation groupTraditional therapy group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • with diagnosed complex intracranial aneurysm by digital subtraction angiography(DSA);
  • got SAH in history;
  • neural functional deficits due to aneurysms;
  • with \<4 in Hunt-Hess Grades;
  • ≥5.0mm in the maximum diameter;
  • \<70 years old;
  • with irregular morphological features and high rupture risk.

You may not qualify if:

  • \>70 in age, with low rupture risk;
  • cannot tolerant the operation;
  • patient or relative refuses to participate the trail;
  • SAH patient with ≥4 Hunt-Hess grading system;
  • \<5.0mm in the maximum diameter.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hospital Capital Medical University

Beijing, Beijing Municipality, 0086, China

RECRUITING

MeSH Terms

Conditions

Intracranial Aneurysm

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular Diseases

Study Officials

  • Jizong Zhao, MD

    Beijing Tiantan Hospital

    STUDY DIRECTOR

Central Study Contacts

Mingze Wang, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Traditional therapy group:the aneurysms will be executed by traditional procedure, including microsurgical clipping, endovascular coiling or stenting, etc. Hybrid operation group: Intervene with hybrid operating techniques, eg. microsurgical clipping+endovascular coiling or with the assistant of balloon occlusion.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

June 26, 2017

First Posted

July 2, 2017

Study Start

April 1, 2016

Primary Completion

June 1, 2019

Study Completion

December 1, 2019

Last Updated

July 2, 2017

Record last verified: 2017-06

Locations